Healthcare · Drug Manufacturers General · NYSE
| Market cap | $159.19B |
|---|---|
| Trailing P/E | 9.2 |
| FCF yield | 5.7% |
| Revenue growth (YoY) | -1.6% |
| EPS growth (YoY) | +3.9% |
| FCF/share growth (YoY) | -7.9% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Pfizer Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Carol Devine Miller | House | Sell | $15,001 - $50,000 | Aug 13, 2026 |
| Michael Rulli | House | Sell | $1,001 - $15,000 | Aug 7, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Aug 5, 2026 |
| Alan Armstrong | Senate | Sell | $50,001 - $100,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Sell | $50,001 - $100,000 | Jul 21, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Jul 16, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Jul 16, 2026 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Apr 7, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Mar 9, 2026 |
| James French Hill | House | Sell | $100,001 - $250,000 | Jan 23, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |